H.B. Fuller Company (FUL) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
9 Jul, 2026Executive summary
Adjusted EBITDA increased 6% year-over-year to $165 million, with margin expansion to 18% and net income rising to $55.4 million.
Organic sales grew 0.4% year-over-year, with volume up 3% and pricing down 2.6%; net revenue rose 1.9% to $918 million, impacted by currency headwinds.
Adjusted EPS was $1.13, up 7% year-over-year.
Construction Adhesives and most of the HHC portfolio showed strong volume growth, offsetting weakness in Engineering Adhesives due to slowing durable goods and solar demand.
Acquired HS Butyl Limited, expanding presence in the waterproofing tape market.
Financial highlights
Q3 net revenue was $917.9 million, up 1.9% year-over-year; adjusted gross profit margin rose 40 bps to 30.4%.
Net income attributable to shareholders was $55.4 million, up from $37.6 million a year ago.
Net working capital as a percentage of annualized revenue improved to 16.1% from 18.1% a year ago.
Net debt-to-adjusted EBITDA was 3.1x, flat sequentially and down from 3.3x a year ago.
Operating cash flow year-to-date was flat, as profitability gains were offset by working capital investments.
Outlook and guidance
Fiscal 2024 net revenue growth expected at ~2%, with organic revenue flat year-over-year.
Adjusted EBITDA guidance narrowed to $610–$620 million (5–7% growth).
Full-year adjusted diluted EPS expected at $4.10–$4.20, up 6–9% year-over-year.
Operating cash flow projected at $325–$350 million.
Price/raw material dynamics expected to be more neutral and less volatile in 2025.
Latest events from H.B. Fuller Company
- Adjusted EBITDA and EPS rose with margin expansion despite a 6.6% organic revenue decline.FUL
Q1 20268 Jul 2026 - Adjusted EBITDA and EPS grew 5% year-over-year, with margin gains and raised full-year guidance.FUL
Q2 20258 Jul 2026 - Q2 2026 saw strong revenue, margin, and EPS growth, with a major medical acquisition announced.FUL
Q2 202625 Jun 2026 - All proposals passed, including director elections and auditor ratification, with no shareholder questions.FUL
AGM 202616 Apr 2026 - Proxy covers director elections, auditor ratification, pay, strong results, and ESG focus.FUL
Proxy Filing4 Mar 2026 - Votes will be cast for director elections, auditor ratification, and executive pay approval.FUL
Proxy Filing4 Mar 2026 - Adjusted EPS up 20% and EBITDA up 10% year-over-year, with 2024 guidance raised.FUL
Q2 20243 Feb 2026 - Margin and EPS growth achieved through cost actions and acquisitions despite revenue headwinds.FUL
Q4 202515 Jan 2026 - FY24 revenue up 1.6%, margin at 16.6%; 2025 outlook cautious with cost and footprint actions.FUL
Q4 202410 Jan 2026